LLII was created on 2025-11-04 by REX Shares. The fund's investment portfolio concentrates primarily on health care equity. LLII seeks to provide weekly distributions through a synthetic covered call strategy on Eli Lilly and Company (NYSE: LLY), while also aiming for 105% to 150% of LLYs daily share price performance. LLY specializes in the discovery, development, and manufacture of medicines in areas such as diabetes, oncology, neuroscience, and immunology.